Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Up 237.8% in August

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the target of a large increase in short interest in the month of August. As of August 14th, there was short interest totaling 1,098 shares, an increase of 237.8% from the July 30th total of 325 shares. Based on an average daily volume of 3,918 shares, the short-interest ratio is currently 0.3 days. Currently, 0.1% of the shares of the company are short sold.

Fidelity Disruptive Medicine ETF Price Performance

NASDAQ FMED opened at $31.64 on Friday. The stock has a market capitalization of $50.62 million, a price-to-earnings ratio of 41.33 and a beta of 0.75. Fidelity Disruptive Medicine ETF has a 1-year low of $23.48 and a 1-year high of $32.89. The business’s fifty day moving average price is $29.47 and its 200-day moving average price is $26.63.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

Hedge funds and other institutional investors have recently made changes to their positions in the business. Jane Street Group LLC grew its position in Fidelity Disruptive Medicine ETF by 0.8% during the first quarter. Jane Street Group LLC now owns 66,382 shares of the company’s stock valued at $1,567,000 after buying an additional 499 shares during the period. Virtu Financial LLC purchased a new stake in shares of Fidelity Disruptive Medicine ETF in the 4th quarter worth $228,000. Finally, Vise Technologies Inc. purchased a new position in Fidelity Disruptive Medicine ETF during the fourth quarter valued at $234,000.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.